Clinical and Fundamental Aspects of Prosthetics and Translocation of Mitral Valve Chordae

NCT ID: NCT03674593

Last Updated: 2025-04-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

64 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-09

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study compares the efficacies of two surgical procedures for the treatment of mitral valve prolapse due to myxomatous degeneration of the mitral valve: the chordae replacement and the translocation of secondary mitral valve chordae.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Summary: This study compares the efficacy and the safety of two surgical procedures for the treatment of mitral valve prolapse due to degeneration of the mitral valve: chordae replacement and the translocation of secondary mitral valve chordae.

In our study, researchers used the loop method proposed by von Oppel and Mohr in 2000. The main principle of the method of prosthetic chordae is the preservation of the native anatomy of the mitral valve. This principle is achieved by the implantation of artificial chordae made of ePTFE Gore-Tex threads.

The chordae replacement method essentially involves five stages:

1. Measuring the required length of the chordae.
2. Forming the loops.
3. Fixation of the group of loops to the papillary muscles.
4. Fixation of the chordal loops to the free edge of the valve.
5. Annuloplasty with a support ring and a hydraulic test to confirm the absence of prolapse.

Chordae translocation is the alternative method, which does not require measurement and selection of chordae lengths. Chordae replacement is technically easier (less aortic clamping time) with comparable results.

The technique of translocation of secondary chordae essentially consists of three stages:

1. Selection of the secondary chordae.
2. Fixation of secondary chordae to the free edge of the valve.
3. Annuloplasty support ring and hydraulic test to confirm the absence of prolapse.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Degenerative Mitral Valve Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Single-center, prospective, semi-open, randomized study
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
Single blind masking (Participant)

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mitral valve chordae prosthesis

Patients of this group receive mitral valve chordae replacement performed in five stages:

1. Measure the required length of the chordae.
2. Forming loops.
3. Fixation of the loop group to the papillary muscles.
4. Fixation of chordal loops to the free edge of the valve.
5. Annuloplasty with a support ring and a hydraulic test to confirm the absence of prolapse.

Group Type EXPERIMENTAL

Mitral valve chordae prosthesis

Intervention Type PROCEDURE

The method consists of five stages:

1. Measure the required length of the chords
2. Forming loops
3. Fixation of the loop group to the papillary muscles
4. Fixation of chordal loops to the free edge of the valve
5. Annuloplasty with a support ring and a hydraulic test to confirm the absence of prolapse

Mitral valve chordae translocation

The technique of translocation of secondary chordae:

The method consists essentially of three stages:

1. Selection of the secondary chordae.
2. Fixation of secondary chordae to the free edge of the valve.
3. Annuloplasty support ring and hydraulic test to confirm the absence of prolapse.

Group Type ACTIVE_COMPARATOR

Mitral valve chordae translocation

Intervention Type PROCEDURE

The method consists essentially of three stages:

1. Selection of the secondary chord.
2. Fixation of secondary chords to the free edge of the valve.
3. Annuloplasty support ring and hydraulic test to confirm the absence of prolapse.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mitral valve chordae prosthesis

The method consists of five stages:

1. Measure the required length of the chords
2. Forming loops
3. Fixation of the loop group to the papillary muscles
4. Fixation of chordal loops to the free edge of the valve
5. Annuloplasty with a support ring and a hydraulic test to confirm the absence of prolapse

Intervention Type PROCEDURE

Mitral valve chordae translocation

The method consists essentially of three stages:

1. Selection of the secondary chord.
2. Fixation of secondary chords to the free edge of the valve.
3. Annuloplasty support ring and hydraulic test to confirm the absence of prolapse.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Chordae prosthesis Chordae translocation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Isolated type II mitral valve insufficiency by A. Carpentier
2. Mitral regurgitation degree \>2
3. Age \>18 years
4. Signed informed consent to participate in the study

Exclusion Criteria

1. Any other cardiac surgeries
2. Age \<18 years
3. Multiple organ failure
4. ReDo procedure
5. Persistent atrial fibrillation
6. Acute infective endocarditis
7. Refusal to sign informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tomsk National Research Medical Center of the Russian Academy of Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elena N. Pavlyukova, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Tomsk NRMC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cardiology Research Institute, Tomsk NRMC

Tomsk, , Russia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Russia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Mitral Valve Chordae

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The China Mviv Registry
NCT05925335 UNKNOWN NA